Integra Lifesciences Holdings (IART) Current Leases (2019 - 2026)

Integra Lifesciences Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Current Leases fell 1.69% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (down 1.69% YoY), while the FY2025 annual figure was $14.0 million, down 3.58% from the prior year.
• Current Leases came in at $13.9 million for Q1 2026 at Integra Lifesciences Holdings, down from $14.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $16.3 million in Q1 2024 to a low of $12.7 million in Q2 2022.
• A 5-year average of $14.4 million and a median of $14.5 million in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases grew 14.71% in 2023 and slipped 13.08% in 2025, its largest moves.
• Integra Lifesciences Holdings' Current Leases stood at $14.6 million in 2022, then advanced by 4.51% to $15.3 million in 2023, then retreated by 4.87% to $14.5 million in 2024, then decreased by 3.58% to $14.0 million in 2025, then fell by 0.62% to $13.9 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $13.9 million, $14.0 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison